CAN016
/ Canwell Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
CAN016, a HER2-targeted dual-payload ADC, phase 1 clinical development
(AACR 2026)
- "Abstract is embargoed at this time."
ADC • Clinical • P1 data • Oncology • HER-2
1 to 1
Of
1
Go to page
1